Crossmark

Cost minimization analysis of brolucizumab in the treatment of neovascular age-related macular degeneration

Crossref DOI link: https://doi.org/10.1016/j.oftale.2022.08.010

Published Print: 2023-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cabrera López, F.

Escobar-Barranco, J.J.

Ventayol, P.

Pérez-Alcántara, F.

Gómez-Baldó, L.

Blanch, C.
License Information

Text and Data Mining valid from 2023-03-01
More Information

This article is maintained by: Elsevier

Article Title: Cost minimization analysis of brolucizumab in the treatment of neovascular age-related macular degeneration

Journal Title: Archivos de la Sociedad Española de Oftalmología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftale.2022.08.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.oftal.2022.08.007

Content Type: article

Copyright: © 2022 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.